Speaker Profile Thumbnail for Craig Lipset

Founder of Clinical Innovation Partners | Expert on Healthcare and Technology | Speaker on Medical Innovation

Craig Lipset Speaking Fee: $20,000 to $30,000

Founder of Clinical Innovation Partners | Expert on Healthcare and Technology | Speaker on Medical Innovation

Speaker Profile Thumbnail for Craig Lipset
Speaking Fee:
$20,000 to $30,000

Travels From:
EWR - Newark, NJ

Primary Topic Category:
Healthcare

Secondary Topic Category:
Science (STEM / STEAM)

 

Craig Lipset Speaker Profile: At A Glance

Craig Lipset is a pioneering figure in clinical trials and medicine development, renowned for his innovative approaches to patient-centric research. He is the Managing Partner of Clinical Innovation Partners, offering strategic guidance to technology and biopharmaceutical firms. Craig's career includes a notable tenure as Head of Clinical Innovation at Pfizer, where he spearheaded groundbreaking remote clinical trials. His personal experience as a patient with a rare pulmonary disease enriches his perspective on the future of digital and decentralized clinical trials.

Craig Lipset is a distinguished leader in the realm of clinical research and pharmaceutical innovation. With over two decades of experience, he has significantly influenced the landscape of clinical trials, emphasizing patient engagement and technological advancement. As the founder of Clinical Innovation Partners, he collaborates with various stakeholders, including tech companies, biopharmaceutical firms, and academic institutions, to drive forward-thinking solutions in clinical research. Before founding Clinical Innovation Partners, Craig served as the Head of Clinical Innovation at Pfizer from 2010 to 2019. During his tenure, he launched the industry's first fully remote clinical trial and several other initiatives that prioritized returning results and data to research participants. His work at Pfizer set new standards for patient-centric research and digital integration in clinical trials. Craig's contributions extend beyond corporate roles. He is actively involved in academia as an adjunct faculty member at Rutgers University and the University of Rochester. He also serves on the boards of the Foundation for Sarcoidosis Research and the MedStar Health Research Institute, where he continues to advocate for patient empowerment and data ownership. Recognized for his innovative contributions, Craig has received numerous accolades, including being listed among PharmaVOICE's most inspiring people in life sciences and CenterWatch's Top 20 Innovators in Clinical Trials. His presentations often explore the future of clinical trials, digital transformation, and the evolving role of patients in medical research, providing valuable insights to audiences worldwide. Craig's unique blend of professional expertise and personal experience as a patient with a rare pulmonary disease enables him to deliver compelling narratives on the intersection of technology, research, and patient advocacy. His vision continues to shape the future of clinical trials, ensuring they are more inclusive, efficient, and patient-centered.
Gotham Artists